SFRP1 and hepatoblastoma: For example, Sha et al. confirmed that the Wnt/β-catenin pathway could act as an effective therapeutic target in hepatoblastoma [27]; Regel et al. revealed that knockdown of SFRP1 promoted the tumorigenesis of hepatoblastoma through activation of Wnt/β-catenin signaling [28].